Additionally, we examined the effects of berberine, known to inhibit NEK7 activity in AKI mice.43 Consistently, berberine-treated mice demonstrated improved survival, decreased serum creatinine, attenuated renal injury, and decreased renal fibrosis compared with PBS-treated mice following injection of cisplatin (Fig. 9h-l). The gene discussed is NEK7; the disease is acute kidney injury.